Premium
Unsuccessful treatment attempt: Cord blood stem cell transplantation in a patient with Niemann–Pick disease type A
Author(s) -
Morel C. F.,
Gassas A.,
Doyle J.,
Clarke J. T. R.
Publication year - 2007
Publication title -
journal of inherited metabolic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 102
eISSN - 1573-2665
pISSN - 0141-8955
DOI - 10.1007/s10545-007-0700-1
Subject(s) - hepatosplenomegaly , failure to thrive , hypotonia , niemann–pick disease , medicine , niemann–pick disease, type c , transplantation , cord blood , acid sphingomyelinase , disease , pediatrics , surgery , sphingomyelin , gastroenterology , pathology , cholesterol
Summary Niemann–Pick disease type A (NP‐A; OMIM 257200) is an autosomal recessive lysosomal storage disorder caused by deficiency of acid sphingomyelinase and resulting in accumulation of sphingomyelin, unesterified cholesterol, and other complex lipids in many tissues. It is characterized by failure to thrive, hepatosplenomegaly, and a rapidly progressive neurodegenerative course culminating in death by 3 years of age. There is no known effective treatment. We report the case of a prenatally diagnosed girl who underwent cord blood stem cell transplantation (CBSCT) at 3 months of age. She was neurologically intact at the time of CBSCT. Hepatosplenomegaly, was detected at 6 weeks of age; the splenomegaly resolved following CBSCT. Recovery was complicated by graft‐versus‐host disease. She subsequently developed and continues to show marked global developmental delay, generalized hypotonia, and signs of neurological regression, despite continued engraftment. Bilateral cherry red spots were detected at 10 months of age, 7 months post‐CBSCT. Although she is doing better than her affected brother, she shows little overall benefit from CBSCT.